Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Relapse Mechanisms and Genomic Landscape Differ in KMT2A -r Pediatric Leukemia in Relation to Relapse Time

Louise Ahlgren, Mattias Pilheden, Helena Sturesson, Varsha Singh, Qirui Zhang, Michael Walsh, Guangchun Song, Anders Castor, Cornelis Jan Pronk, Pauline Schneider, Ronald W. Stam, Gisela Barbany, Katja Pokrovskaja Tamm, Jonas Abrahamsson, Linda Fogelstrand, Olli Lohi, Jing Ma, Jinghui Zhang, Anna K. Hagstroem-Andersson

Blood (2023) 142 (Supplement 1): 2978.

https://doi.org/10.1182/blood-2023-185044

Published: 2023

Journal Articles

The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia

Blood (2023) 141 (23): 2853–2866.

https://doi.org/10.1182/blood.2022019425

Published: 2023

Includes: Supplemental data

Journal Articles

The Rise and Fall of Leukemia Clones in Longitudinal Samples from Diagnosis to Relapse in KMT2A- rearranged Infant and Childhood Leukemia

Louise Ahlgren, Mattias Pilheden, Helena Sturesson, Varsha Singh, Qirui Zhang, Anders Castor, Cornelis Jan Pronk, Gisela Barbany, Katja Pokrovskaja Tamm, Linda Fogelstrand, Michael P Walsh, Guangchun Song, Jinghui Zhang, Jing Ma, Anna Hagstroem-Andersson

Blood (2022) 140 (Supplement 1): 9189–9190.

https://doi.org/10.1182/blood-2022-165869

Published: 2022

Journal Articles

The Molecular Landscape of KMT2A -Rearranged Leukemia from Infancy to Adulthood Reveals Age and Leukemia-Specific Mutational Patterns

Blood (2021) 138 (Supplement 1): 3479.

https://doi.org/10.1182/blood-2021-152082

Published: 2021

Journal Articles

Multinational Study on the Clinical and Genetic Features of the ERCC6L2-Disease

Marja Hakkarainen, Suvi P. M. Douglas, Tom Vulliamy, Inderjeet Dokal, Jean Soulier, Lise Larcher, Riitta Niinimäki, Timo Siitonen, Eva Hellstrom Lindberg, Gisela Barbany, Bianca Tesi, Amir Asher Kuperman, Hannah Tamary, Sharon Jackson, Outi Kilpivaara, Ulla Wartiovaara-Kautto

Blood (2021) 138 (Supplement 1): 864.

https://doi.org/10.1182/blood-2021-145039

Published: 2021

Journal Articles

DNA Methylation-Based Subtype Prediction for Pediatric Acute Lymphoblastic Leukemia (ALL)

Blood (2014) 124 (21): 490.

https://doi.org/10.1182/blood.V124.21.490.490

Published: 2014

Journal Articles

Novel Focal Gene Deletions in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Detected By Array Comparative Genomic Hybridization

Ingegerd Ivanov Öfverholm, MD, Anh Nhi Tran, PhD, Vasilios Zachariadis, MD, Mats Heyman, MD PhD, Eva Rudd, MD PhD, Elisabeth Syk Lundberg, MD PhD, Magnus Nordenskjöld, MD, PhD, Ann Nordgren, MD PhD, Gisela Barbany, MD PhD

Blood (2014) 124 (21): 1085.

https://doi.org/10.1182/blood.V124.21.1085.1085

Published: 2014

Journal Articles

Leukemic Stem Cell Quantification Is Of Prognostic Value In Newly Diagnosed Patients In Chronic Phase Chronic Myeloid Leukemia (CML-CP) Receiving Nilotinib Therapy: Results From The ENEST1st Stem Cell Substudy

Noortje Thielen, MD, Johan Richter, MD, PhD, Gisela Barbany, MD PhD, Thoas Fioretos, MD PhD, Frank Giles, MD MB, Bjorn T Gjertsen, MD PhD, Andreas Hochhaus, MD, Gert J. Ossenkoppele, MD PhD, Kimmo Porkka, MD, PhD, Gerrit Jan Schuurhuis, PhD, Sieghart Sopper, PhD, Leif Stenke, MD, PhD, Sara Thunberg, PhD, Dominik Wolf, MD, Jeroen Janssen, MD PhD, Satu Mustjoki, MD, PhD

Blood (2013) 122 (21): 649.

https://doi.org/10.1182/blood.V122.21.649.649

Published: 2013

Journal Articles

Favorable Therapeutic Responses in Newly Diagnosed CML-CP Patients Induced by Dasatinib Are Reflected At the CD34+CD38+ Progenitor Cell but Not At the CD34+CD38− Stem Cell Level: Results From Randomized NordCML006 Study

Blood (2011) 118 (21): 784.

https://doi.org/10.1182/blood.V118.21.784.784

Published: 2011

Journal Articles

Landmark Analysis of Imatinib Treatment in CML Chronic Phase: ES-FISH <10% Ph+ At 3 Months Associated with Better Cytogenetic Response and Improved Long-Term Event-Free Survival

Anne-Charlotte Ohm, M.D., Gisela Barbany, MD, PhD, Ingrid Arvidsson, Lab., tech., Robert Hast, M.D., Ph.D., Leif Stenke, MD, PhD

Blood (2011) 118 (21): 1702.

https://doi.org/10.1182/blood.V118.21.1702.1702

Published: 2011

Journal Articles

The Proportion of Ph+ CD34 + CD38 neg Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI-Therapy. Data From a Randomized Phase II NordCML006 Study

Blood (2010) 116 (21): 667.

https://doi.org/10.1182/blood.V116.21.667.667

Published: 2010

Journal Articles

Stability of Conversion Factors for BCR-ABL Monitoring -– Implications for the Frequency of Validation Rounds

Martin C. Müller, MD, Umang Munjal, PhD, Philipp Erben, MD, Thomas Lion, MD, PhD, Gerlinde Mitterbauer-Hohendanner, MD, Hakim El Housni, MD, Nancy Boeckx, Renata Zadro, MD, PhD, Jiri Mayer, MD, PhD, Peter Rohon, MD, Jana Rulcova, PhD, Lykke Grubach, Kadri Raudsepp, MD, Veli Kairisto, MD, PhD, Francois-Xavier Mahon, MD, PhD, Claude Preudhomme, MD, Sandrine Hayette, MD, Jean Gabert, MD, Jean-Michel Cayuela, MD, PhD, Christian Thiede, Lars Galonska, MD, Heike Pfeifer, MD, Carsten Hirt, MD, Philippe Schafhausen, MD, Nils von Neuhoff, PhD, Martin Roskos, MD, Christiane Pott, MD, Thoralf Lange, MD, Georg Hess, MD, Susanne Schnittger, PhD, Annika Dufour, MD, Steffen Koschmieder, MD, Frank Stegelmann, MD, Katerina Zoi, MD, PhD, Kostas Stamatopoulos, Hajnalka Andrikovics, MD, PhD, Tali Tohami, MD, PhD, Giovanni Martinelli, MD, Barbara Izzo, PhD, Enrico Gottardi, MD, Mindaugas Stoskus, Dag Andre Nymoen, MD, Tomasz Sacha, MD, Joana Diamond, MD, PhD, Rodica Talmaci, PhD, Andrey Misyurin, MD, Michael V. Dubina, MD, Tadej Pajic, MD, PhD, Josep F. Nomdedeu, MD, Dolors Colomer, MD, PhD, Gisela Barbany-Bustinza, MD, Hans Ehrencrona, MD, Elisabeth Oppliger Leibundgut, PhD, Jeroen Janssen, MD, Vincent H. J. van der elden, MD, Peter J.M. Valk, MD, PhD, Ugur Ozbek, MD, PhD, Lihui Wang, Gareth Gerrard, PhD, Helen E White, PhD, Thomas Schenk, MD, Thomas Ernst, MD, Rüdiger Hehlmann, MD, Giuseppe Saglio, MD, PhD, Andreas Hochhaus, MD, Nicholas C. P. Cross, PhD

Blood (2010) 116 (21): 893.

https://doi.org/10.1182/blood.V116.21.893.893

Published: 2010

Journal Articles

Landmark Analyses of BCR-ABL Using ES-FISH Early After Start of Imatinib Treatment to Newly Diagnosed CMLcp Patients Predicts Longterm Clinical Outcome.

Lotta Ohm, MD, Robert Hast, MD, PhD, Ingrid Arvidsson, Gisela Barbany, Leif Stenke, MD, PhD

Blood (2009) 114 (22): 4269.

https://doi.org/10.1182/blood.V114.22.4269.4269

Published: 2009

Journal Articles

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Blood (2007) 110 (11): 4559.

https://doi.org/10.1182/blood.V110.11.4559.4559

Published: 2007

Journal Articles

The EuroChimerism Concept for a Standardized Approach to Chimerism Analysis Following Allogeneic Stem Cell Transplantation.

Thomas Lion, Marcel Tilanus, Hélène Cavé, Mark Lawler, Anna Serra, Andrea Biondi, Jacques van Dongen, Marcos González, Gisela Barbany, Eddy Roosnek, Colin Steward, Peter Bader

Blood (2006) 108 (11): 621.

https://doi.org/10.1182/blood.V108.11.621.621

Published: 2006

Journal Articles

Identification of Genes That Potentially Allow Prediction of Interferon Response in Chronic Phase CML Diagnostic Samples through Gene Expression Analysis.

Gisela Barbany, MD, PhD, Anette Hagberg, PhD, Ulla Strömberg-Olsson, MD, Anders Isaksson, PhD, Mats Bengtzon, MD, PhD, Martin Höglund, MD, PhD, Bengt Simonsson, MD, PhD

Blood (2005) 106 (11): 4832.

https://doi.org/10.1182/blood.V106.11.4832.4832

Published: 2005

Journal Articles

Impact of RNA Stabilization on Minimal Residual Disease Assessment in Chronic Myeloid Leukemia.

Ingrid Thörn, Ulla Olsson-Strömberg, Cecilia Ohlsen, Anna-Maria Jonsson, Ulf Klangby, Bengt Simonsson, Gisela Barbany

Blood (2005) 106 (11): 4490.

https://doi.org/10.1182/blood.V106.11.4490.4490

Published: 2005

Journal Articles

Microarray Gene Expression Studies Reveal Potential Classifier Genes That Allow Prediction of Response to Interferon in Chronic Myeloid Leukemia Patients.

Gisela Barbany, MD PhD, Anette Hagberg, PhD, Ulla Olsson Strömberg, MD, Anders Isaksson, PhD, Bengt Simonsson, MD PhD

Blood (2004) 104 (11): 4409.

https://doi.org/10.1182/blood.V104.11.4409.4409

Published: 2004

NARROW

The Relapse Mechanisms and Genomic Landscape Differ in KMT2A -r Pediatric Leukemia in Relation to Relapse Time

The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia

The Rise and Fall of Leukemia Clones in Longitudinal Samples from Diagnosis to Relapse in KMT2A- rearranged Infant and Childhood Leukemia

The Molecular Landscape of KMT2A -Rearranged Leukemia from Infancy to Adulthood Reveals Age and Leukemia-Specific Mutational Patterns

Multinational Study on the Clinical and Genetic Features of the ERCC6L2-Disease

DNA Methylation-Based Subtype Prediction for Pediatric Acute Lymphoblastic Leukemia (ALL)

Novel Focal Gene Deletions in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Detected By Array Comparative Genomic Hybridization

Leukemic Stem Cell Quantification Is Of Prognostic Value In Newly Diagnosed Patients In Chronic Phase Chronic Myeloid Leukemia (CML-CP) Receiving Nilotinib Therapy: Results From The ENEST1st Stem Cell Substudy

Favorable Therapeutic Responses in Newly Diagnosed CML-CP Patients Induced by Dasatinib Are Reflected At the CD34+CD38+ Progenitor Cell but Not At the CD34+CD38− Stem Cell Level: Results From Randomized NordCML006 Study

Landmark Analysis of Imatinib Treatment in CML Chronic Phase: ES-FISH <10% Ph+ At 3 Months Associated with Better Cytogenetic Response and Improved Long-Term Event-Free Survival

Stability of Conversion Factors for BCR-ABL Monitoring -– Implications for the Frequency of Validation Rounds

Landmark Analyses of BCR-ABL Using ES-FISH Early After Start of Imatinib Treatment to Newly Diagnosed CMLcp Patients Predicts Longterm Clinical Outcome.

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

The EuroChimerism Concept for a Standardized Approach to Chimerism Analysis Following Allogeneic Stem Cell Transplantation.

Identification of Genes That Potentially Allow Prediction of Interferon Response in Chronic Phase CML Diagnostic Samples through Gene Expression Analysis.

Impact of RNA Stabilization on Minimal Residual Disease Assessment in Chronic Myeloid Leukemia.

Microarray Gene Expression Studies Reveal Potential Classifier Genes That Allow Prediction of Response to Interferon in Chronic Myeloid Leukemia Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only